Table 1 Characteristics of patients and controls
Characteristic | Healthy controls (n = 30) | Patients with pSS (n = 30) |
|---|---|---|
Demographic | ||
Female, n (%) | 30 (100) | 29 (97) |
Age, mean (SD), years* | 39.9 (9.4) | 61.1 (10.8) |
Disease duration, mean (SD), years * | NA | 4.7 (6.6) |
Clinical manifestation, n (%) | ||
Ocular symptoms | NA | 18 (60) |
Oral symptoms | NA | 21 (70) |
Objectively assessed dryness | NA | 24 (80) |
Anti-SSA positivity | NA | 24 (80) |
Anti-SSB positivity | NA | 14 (48) |
Lymphocytic sialadenitis with focus score ≥1 | NA | 12 (40) |
ESSDAI, mean (SD) * | NA | 2.6 (4.2) |
Treatment | ||
Corticosteroid | NA | 1 (3) |
Immunosuppressant | NA | 0 (0) |